Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2008-7-30
pubmed:abstractText
The current study was conducted to evaluate the effects of low-dose craniospinal irradiation (CSI) combined with chemotherapy on non-metastatic embryonal tumors in the central nervous system (CNS), including medulloblastoma and supra-tentorial primitive neuroectodermal tumors (ST-PNET).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1465-3621
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
486-92
pubmed:meshHeading
pubmed-meshheading:18573848-Adolescent, pubmed-meshheading:18573848-Adult, pubmed-meshheading:18573848-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18573848-Brain Neoplasms, pubmed-meshheading:18573848-Child, pubmed-meshheading:18573848-Child, Preschool, pubmed-meshheading:18573848-Cisplatin, pubmed-meshheading:18573848-Combined Modality Therapy, pubmed-meshheading:18573848-Cranial Irradiation, pubmed-meshheading:18573848-Dose-Response Relationship, Radiation, pubmed-meshheading:18573848-Etoposide, pubmed-meshheading:18573848-Female, pubmed-meshheading:18573848-Humans, pubmed-meshheading:18573848-Ifosfamide, pubmed-meshheading:18573848-Infant, pubmed-meshheading:18573848-Male, pubmed-meshheading:18573848-Medulloblastoma, pubmed-meshheading:18573848-Neuroectodermal Tumors, Primitive, pubmed-meshheading:18573848-Radiotherapy Dosage, pubmed-meshheading:18573848-Supratentorial Neoplasms, pubmed-meshheading:18573848-Survival Analysis
pubmed:year
2008
pubmed:articleTitle
Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
pubmed:affiliation
Hokkaido University School of Medicine, North-15 West-7, Kita-ku, Sapporo, Japan. kyasuda@radi.med.hokudai.ac.jp
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't